SMARCD3 and neoplasm: Significant differences in mouse survival and tumour sizes were not observed between MYCS62D-induced and SMARCD3 + MYCS62D-induced tumours; however, SMARCD3 OE promoted tumour spinal metastasis of MYCS62D-induced tumours (Extended Data Fig. 3k–m).